Back to Search
DANIEL HICKMAN, DMD
DMD
General Practice Dentistry
NPI: 1982583365Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
DN30974(FL)
Research & Publications (20)
A calibration phantom for direct, in vivo measurement of 241Am in the axillary lymph nodes.
PMID 19667805·Health Phys·2009
8-other
In vitro metabolism of the novel, highly selective oral angiogenesis inhibitor motesanib diphosphate in preclinical species and in humans.
PMID 19372226·Drug Metab Dispos·2009
8-other
Endpoints for mouse abdominal tumor models: refinement of current criteria.
PMID 19619413·Comp Med·2009
7-preclinical
Collaborative studies and animal reuse: the other IACUC should decide.
PMID 18216792·Lab Anim (NY)·2008
7-preclinical
Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens.
PMID 18779858·PLoS One·2008
7-preclinical
A cost-effective and efficacious method of pinworm treatment for large colonies of mice.
PMID 18568009·Lab Anim (NY)·2008
7-preclinical
2-amino-1,3-thiazol-4(5H)-ones as potent and selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: enzyme-ligand co-crystal structure and demonstration of pharmacodynamic effects in C57Bl/6 mice.
PMID 18419108·J Med Chem·2008
7-preclinical
A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity.
PMID 18334632·Proc Natl Acad Sci U S A·2008
7-preclinical
An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines.
PMID 18931063·J Gen Virol·2008
7-preclinical
Structural characterization and pharmacodynamic effects of an orally active 11beta-hydroxysteroid dehydrogenase type 1 inhibitor.
PMID 18069989·Chem Biol Drug Des·2008
7-preclinical
Further studies with the 2-amino-1,3-thiazol-4(5H)-one class of 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: reducing pregnane X receptor activity and exploring activity in a monkey pharmacodynamic model.
PMID 19053753·J Med Chem·2008
7-preclinical
Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor.
PMID 17343372·J Med Chem·2007
7-preclinical
Pandemic influenza: preventing the emergence of novel strains and countermeasures to ameliorate its effects.
PMID 18220962·Infect Disord Drug Targets·2007
6-review
Mapping mandibular rest in humans utilizing electromyographic patterns from masticatory muscles.
PMID 17983126·Cranio·2007
8-other
Staphylococcus-induced urolithiasis in estrogen-treated ovariectomized nude mice.
PMID 17645298·J Am Assoc Lab Anim Sci·2007
5-case
Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.
PMID 17517595·Proc Natl Acad Sci U S A·2007
4-observational
Immunization with liposome-anchored pegylated peptides modulates doxorubicin sensitivity in P-glycoprotein-expressing P388 cells.
PMID 17517470·Cancer Lett·2007
7-preclinical
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studies.
PMID 17490879·Bioorg Med Chem Lett·2007
7-preclinical
Telehealth screen for depression in a chronic illness care management program.
PMID 17309355·Telemed J E Health·2007
8-other
The laboratory animal boards study group: A multifaceted tool for preparation for the American College for Laboratory Medicine board examination.
PMID 16884177·J Am Assoc Lab Anim Sci·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2437 ENTERPRISE RD
ORANGE CITY, FL 32763 - Phone
- (386) 774-8009
Quick Facts
- NPI
- 1982583365
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile